SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-129266
Filing Date
2023-12-26
Accepted
2023-12-26 17:15:24
Documents
12
Period of Report
2023-12-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2333710d1_8k.htm   iXBRL 8-K 26425
  Complete submission text file 0001104659-23-129266.txt   199463

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA repl-20231226.xsd EX-101.SCH 3018
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE repl-20231226_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE repl-20231226_pre.xml EX-101.PRE 22361
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2333710d1_8k_htm.xml XML 3301
Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

IRS No.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38596 | Film No.: 231514021
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)